Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2142 USD
−108.65 M USD
24.60 M USD
321.62 M
About JW (CAYMAN) THERAPEUTICS CO. LTD
Sector
Industry
CEO
MIn Liu
Website
Headquarters
Shanghai
Founded
2017
FIGI
BBG00ZGY3SP8
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JWCTF is 0.2550 USD — it has increased by 25.00% in the past 24 hours. Watch JW CAYMAN THERAPEUTICS CO LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange JW CAYMAN THERAPEUTICS CO LTD. stocks are traded under the ticker JWCTF.
We've gathered analysts' opinions on JW CAYMAN THERAPEUTICS CO LTD. future price: according to them, JWCTF price has a max estimate of 0.31 USD and a min estimate of 0.31 USD. Watch JWCTF chart and read a more detailed JW CAYMAN THERAPEUTICS CO LTD. stock forecast: see what analysts think of JW CAYMAN THERAPEUTICS CO LTD. and suggest that you do with its stocks.
JWCTF reached its all-time high on Jul 15, 2021 with the price of 2.8500 USD, and its all-time low was 0.0004 USD and was reached on Sep 2, 2022. View more price dynamics on JWCTF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JWCTF stock is 20.07% volatile and has beta coefficient of 1.42. Track JW CAYMAN THERAPEUTICS CO LTD. stock price on the chart and check out the list of the most volatile stocks — is JW CAYMAN THERAPEUTICS CO LTD. there?
Today JW CAYMAN THERAPEUTICS CO LTD. has the market capitalization of 68.59 M, it has increased by 34.94% over the last week.
Yes, you can track JW CAYMAN THERAPEUTICS CO LTD. financials in yearly and quarterly reports right on TradingView.
JW CAYMAN THERAPEUTICS CO LTD. is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
JWCTF earnings for the last half-year are −0.08 USD per share, whereas the estimation was −0.09 USD, resulting in a 9.38% surprise. The estimated earnings for the next half-year are −0.09 USD per share. See more details about JW CAYMAN THERAPEUTICS CO LTD. earnings.
JW CAYMAN THERAPEUTICS CO LTD. revenue for the last half-year amounts to 11.94 M USD, despite the estimated figure of 14.82 M USD. In the next half-year revenue is expected to reach 18.17 M USD.
JWCTF net income for the last half-year is −33.33 M USD, while the previous report showed −53.61 M USD of net income which accounts for 37.82% change. Track more JW CAYMAN THERAPEUTICS CO LTD. financial stats to get the full picture.
No, JWCTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 398.00 employees. See our rating of the largest employees — is JW CAYMAN THERAPEUTICS CO LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JW CAYMAN THERAPEUTICS CO LTD. EBITDA is −57.53 M USD, and current EBITDA margin is −276.69%. See more stats in JW CAYMAN THERAPEUTICS CO LTD. financial statements.
Like other stocks, JWCTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JW CAYMAN THERAPEUTICS CO LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JW CAYMAN THERAPEUTICS CO LTD. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JW CAYMAN THERAPEUTICS CO LTD. stock shows the sell signal. See more of JW CAYMAN THERAPEUTICS CO LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.